Portable Respiratory Monitoring System

MediPines Corporation

Monitors and detects changes in pulmonary gas exchange in diseased states.

Courtesy of WHO Compendium 2021

Product description Brand name and product description

The MediPines AGM100 provides real-time measurements of 12 respiratory metrics by sampling a patient’s normal breathing and can be used to detect respiratory impairments such as those resulting from COVID-19. The device is non-invasive, portable, and displays all respiratory measurements in one output screen.

This product was selected for inclusion in WHO’s 2021 Compendium of Innovative Health Technologies for Low‐Resource Settings.

Target region(s) Target region for distribution/implementation (listed by country if specified)

Globally

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

This product is available from the manufacturer.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

12,000 USD per unit, 47 USD for consumables

Competitive landscape Similar products available on the market. May not be a comprehensive listing.
SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Good health and well-being

Target user(s) Target user/consumer base (country, income segment)

Any trained healthcare professional with the need for portable respiratory measurements of patients.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F